We are live on
!
Find out more
CCM
Convector Capital Management Portfolio holdings
AUM
$54.5M
1-Year Est. Return
11.63%
This Fund
S&P 500
This Quarter
Est. Return
-2.39%
1 Year Est. Return
+11.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$72.5M
AUM Growth
-$26.4M
(-27%)
Cap. Flow
-$23.3M
Cap. Flow
% of AUM
-32.12%
Top 10 Holdings %
Top 10 Hldgs %
56.93%
Holding
37
New
5
Increased
3
Reduced
20
Closed
7
Top Buys
| 1 |
Chevron
CVX
|
+$2.48M |
| 2 |
Liberty Global Class A
LBTYA
|
+$2.27M |
| 3 |
Bausch Health
BHC
|
+$1.9M |
| 4 |
Procter & Gamble
PG
|
+$1.48M |
| 5 |
JPMorgan Chase
JPM
|
+$1.25M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$4.09M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$3.91M |
| 3 |
Apple
AAPL
|
+$3.81M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$3.1M |
| 5 |
AET
Aetna Inc
AET
|
+$2.25M |
Sector Composition
| 1 | Technology | 22.35% |
| 2 | Healthcare | 21.61% |
| 3 | Industrials | 10.46% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Energy | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vanda Pharmaceuticals
VNDA
$327M
| $783K | 1.08% |
70,000
-62,000
| -47% | -$600K |
|
|
RLYP
27
DELISTED
RELYPSA INC COM
RLYP
| $752K | 1.04% |
40,640
-18,960
| -32% | -$333K |
|
|
TWTR
28
DELISTED
Twitter, Inc.
TWTR
| $710K | 0.98% |
+42,000
| New | +$656K |
|
|
NBIS
29
Nebius Group N.V.
NBIS
$45.1B
| $546K | 0.75% |
25,000
-25,000
| -50% | -$486K |
|
|
FLXN
30
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $359K | 0.5% |
+24,000
| New | +$302K |
|
|
DVAX
31
DELISTED
Dynavax Technologies
DVAX
| – | – |
-50,074
| Closed | -$963K |
|
32
Humana
HUM
$48B
| – | – |
-9,020
| Closed | -$1.65M |
|
33
Petrobras
PBR
$116B
| – | – |
-300,000
| Closed | -$1.75M |
|
|
34
Teva Pharmaceuticals
TEVA
$37.3B
| – | – |
-58,000
| Closed | -$3.1M |
|
|
RSX
35
DELISTED
VanEck Russia ETF
RSX
| – | – |
-20,000
| Closed | -$327K |
|
|
AET
36
DELISTED
Aetna Inc
AET
| – | – |
-20,000
| Closed | -$2.25M |
|
|
BXLT
37
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| – | – |
-47,000
| Closed | -$1.9M |
|
Similar funds
IAM
HPA
EL
KCP
LSVM
BS
CSM
CCG
Convector Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Convector Capital Management held 37 positions worth $72.5M, down 27% from $98.9M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Convector Capital Management withdrew a net $23.3M in Q2 2016, closing 7 positions and reducing 20 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $3.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Convector Capital Management opened a new position in Chevron worth $2.59M.
- Convector Capital Management's largest Q2 2016 buy was Chevron: 24,680 shares worth $2.59M.
- Convector Capital Management added most to Bausch Health in Q2 2016, an estimated $1.9M increase.
- Convector Capital Management's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $4.09M.
- Convector Capital Management fully exited Teva Pharmaceuticals in Q2 2016, selling an estimated $3.1M.
- Convector Capital Management's ten largest holdings make up 57% of its $72.5M portfolio in Q2 2016.
- Convector Capital Management opened 5 new positions and closed 7 in Q2 2016.
- Convector Capital Management's portfolio value fell 27% quarter-over-quarter to $72.5M.
Based on Convector Capital Management's 13F filing for Q2 2016, filed 4 Aug 2016.